2013 年围产期健康指标：加拿大公共卫生署围产期监测系统的监测报告。
Perinatal health indicators 2013: a surveillance report by the Public Health Agency of Canada's Perinatal Surveillance System.
机构信息
Health Surveillance and Epidemiology Division, Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario, Canada.
出版信息
Health Promot Chronic Dis Prev Can. 2015 Mar;35(1):23-4. doi: 10.24095/hpcdp.35.1.05.
Abstract
The Canadian Perinatal Surveillance System (CPSS) is a national health surveillance program of the Public Health Agency of Canada. The CPSS mandate is to monitor and report on key indicators of maternal, fetal and infant health. These indicators include both determinants and outcomes of perinatal health. Perinatal Health Indicators 2013 reports on 13 priority indicators using the most recent data from vital statistics, hospitalizations, the Canadian Community Health Survey and the National Longitudinal Survey of Children and Youth.
摘要
加拿大围产儿监测系统（CPSS）是加拿大公共卫生局的一项国家健康监测计划。CPSS 的任务是监测和报告孕产妇、胎儿和婴儿健康的关键指标。这些指标既包括围产儿健康的决定因素，也包括其结果。《2013 年围产健康指标报告》利用最新的人口统计数据、住院数据、加拿大社区健康调查数据和全国儿童与青年纵向调查数据，对 13 项优先指标进行了报告。
相似文献
1
Perinatal health indicators 2013: a surveillance report by the Public Health Agency of Canada's Perinatal Surveillance System.2013 年围产期健康指标：加拿大公共卫生署围产期监测系统的监测报告。
Health Promot Chronic Dis Prev Can. 2015 Mar;35(1):23-4. doi: 10.24095/hpcdp.35.1.05.
2
Congenital anomalies in Canada 2013: a perinatal health surveillance report by the Public Health Agency of Canada's Canadian Perinatal Surveillance System.加拿大 2013 年先天性异常：加拿大公共卫生局加拿大围产期监测系统的围产期健康监测报告。
Health Promot Chronic Dis Prev Can. 2015 Mar;35(1):21-2. doi: 10.24095/hpcdp.35.1.04.
3
Release notice - Perinatal Health Indicators (PHI) Data Tool.发布通知 - 围产健康指标（PHI）数据工具。
Health Promot Chronic Dis Prev Can. 2024 Aug;44(7-8):349. doi: 10.24095/hpcdp.44.7/8.07.
4
5
The Canadian maternity experiences survey: an overview of findings.加拿大孕产妇经历调查：研究结果概述
J Obstet Gynaecol Can. 2008 Mar;30(3):217-228. doi: 10.1016/S1701-2163(16)32758-X.
6
Canada's pregnancy-related mortality rates: doing well but room for improvement.加拿大与妊娠相关的死亡率：表现良好但仍有改进空间。
Clin Invest Med. 2015 Feb 6;38(1):E15-22. doi: 10.25011/cim.v38i1.22410.
7
Monitoring positive mental health and its determinants in Canada: the development of the Positive Mental Health Surveillance Indicator Framework.监测加拿大的积极心理健康及其决定因素：积极心理健康监测指标框架的制定。
Health Promot Chronic Dis Prev Can. 2016 Jan;36(1):1-10. doi: 10.24095/hpcdp.36.1.01.
8
Congenital anomalies surveillance in Canada.加拿大的先天性异常监测
Can J Public Health. 2008 Nov-Dec;99(6):483-5. doi: 10.1007/BF03403781.
9
Infant mortality in Canada.加拿大的婴儿死亡率。
J Obstet Gynaecol Can. 2009 Apr;31(4):351-352. doi: 10.1016/S1701-2163(16)34152-4.
10
Maternal and Perinatal Health in Umbria region in 2012.2012年翁布里亚地区的孕产妇和围产期健康状况
Ann Ig. 2015 May-Jun;27(3):580-9. doi: 10.7416/ai.2015.2049.
引用本文的文献
1
Integrative Approaches to Prostate Disease Management: Nutrition, Exercise, and Lifestyle Modifications.前列腺疾病管理的综合方法：营养、运动与生活方式调整
Am J Mens Health. 2025 May-Jun;19(3):15579883251344571. doi: 10.1177/15579883251344571. Epub 2025 Jun 23.
2
Brief Report: Trends of Congenital Syphilis among Neonates in Canada 2012-2023.简报：2012 - 2023年加拿大新生儿先天性梅毒的趋势
J Pediatr Clin Pract. 2025 Apr 30;16:200146. doi: 10.1016/j.jpedcp.2025.200146. eCollection 2025 Jun.
3
Receptiveness to participating in cannabis research in pregnancy: a survey study at The Ottawa Hospital.孕期参与大麻研究的接受度：渥太华医院的一项调查研究
F1000Res. 2021 May 24;10:413. doi: 10.12688/f1000research.51947.1. eCollection 2021.
4
Prediction of obstetric outcomes in sickle cell patients based on tricuspid regurgitant velocity.基于三尖瓣反流速度预测镰状细胞病患者的产科结局
Obstet Med. 2024 Jul 25;18(3):180-185. doi: 10.1177/1753495X241263135. eCollection 2025 Sep.
5
Prediction of outcomes for rescue cerclage in cervical insufficiency: A multicenter retrospective study.宫颈机能不全患者紧急宫颈环扎术结局的预测：一项多中心回顾性研究。
Int J Med Sci. 2024 Mar 25;21(5):896-903. doi: 10.7150/ijms.87941. eCollection 2024.
6
Increased mortality in infants with abnormal T-cell receptor excision circles.T细胞受体切除环异常的婴儿死亡率增加。
Pediatr Res. 2024 Jul;96(1):199-207. doi: 10.1038/s41390-024-03121-7. Epub 2024 Mar 5.
7
Tranexamic acid for the prevention of postpartum haemorrhage: the TAPPH-1 pilot randomized trial and lessons learned for trials in Canadian obstetrics.氨甲环酸预防产后出血：TAPPH-1 试验的初步随机试验及加拿大产科试验的经验教训。
Sci Rep. 2023 Mar 18;13(1):4512. doi: 10.1038/s41598-023-30947-8.
8
Neonatal Outcomes of Mothers With a Disability.母亲残疾与新生儿结局的关系
Pediatrics. 2022 Sep 1;150(3). doi: 10.1542/peds.2021-055318.
9
Cost of neonatal intensive care for extremely preterm infants in Canada.加拿大极早产儿新生儿重症监护的费用。
Transl Pediatr. 2021 Jun;10(6):1630-1636. doi: 10.21037/tp-21-36.
10
Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort.在一项跨国、基于人群的队列研究中，比较昂丹司琼与其他止吐药物治疗的患者的妊娠结局。
JAMA Netw Open. 2021 Apr 1;4(4):e215329. doi: 10.1001/jamanetworkopen.2021.5329.
Zotero 插件